Dablo, Erwin .
HRN: 29-11-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/06/2026
06/13/2026
IV
600mg
Q8
Dm Foot
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines